Search Results - Rhode, Peter

Refine Results
  1. 1
    Points: Clinical Algorithms: Compulsory detention in hospital under the Mental Health Act 1983

    Points: Clinical Algorithms: Compulsory detention in hospital under the Mental Health Act 1983 by Rhode, Peter

    Published 1987
    Get full text
    Text
    Save to List
    Saved in:
  2. 2
    The IL-15-based superagonist ALT-803 promotes the antigen-independent conversion of memory CD8(+) T cells into innate-like effector cells with antitumor activity

    The IL-15-based superagonist ALT-803 promotes the antigen-independent conversion of memory CD8(+) T cells into innate-like effector cells with antitumor activity by Wong, Hing C, Jeng, Emily K, Rhode, Peter R

    Published 2013
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  3. 3
    Enhanced efficacy of IL-15-based ALT-803 superagonist complex in combination with immune checkpoint inhibitors in hematologic and metastatic mouse tumor models

    Enhanced efficacy of IL-15-based ALT-803 superagonist complex in combination with immune checkpoint inhibitors in hematologic and metastatic mouse tumor models by Xu, Wenxin, Marcus, Warren D, Rhode, Peter R, Wong, Hing C

    Published 2014
    Get full text Get full text
    Text
    Save to List
    Saved in:
  4. 4
    Evaluation of a novel CD20-targeted IL-15 immunotherapeutic with potent activity against B cell lymphoma

    Evaluation of a novel CD20-targeted IL-15 immunotherapeutic with potent activity against B cell lymphoma by Liu, Bai, Kong, Lin, Marcus, Warren D, Chen, Xiaoyue, Han, Kaiping, Rhode, Peter R, Wong, Hing C

    Published 2014
    Get full text Get full text
    Text
    Save to List
    Saved in:
  5. 5
    CITN-06: a Phase I/expansion trial of alt-803, an IL-15 superagonist, in patients with advanced melanoma

    CITN-06: a Phase I/expansion trial of alt-803, an IL-15 superagonist, in patients with advanced melanoma by Margolin, Kim, Wong, Hing C, Morishima, Chihiro, Hernandez, Liza, Ernstoff, Marc, Rhode, Peter R, Waldmann, Thomas A

    Published 2014
    Get full text Get full text
    Text
    Save to List
    Saved in:
  6. 6
    A phase I study evaluating the pharmacokinetics, safety and tolerability of an antibody-based tissue factor antagonist in subjects with acute lung injury or acute respiratory distress syndrome

    A phase I study evaluating the pharmacokinetics, safety and tolerability of an antibody-based tissue factor antagonist in subjects with acute lung injury or acute respiratory distr... by Morris, Peter E, Steingrub, Jay S, Huang, Bee Y, Tang, Shamay, Liu, Patrick M, Rhode, Peter R, Wong, Hing C

    Published 2012
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  7. 7
    The IL-15 superagonist ALT-803 enhances anti-CD20 antibody-directed NK cell ADCC and in vivo clearance of B cell lymphomas

    The IL-15 superagonist ALT-803 enhances anti-CD20 antibody-directed NK cell ADCC and in vivo clearance of B cell lymphomas by Rosario, Maximillian, Liu, Bai, Kong, Lin, Schneider, Stephanie E, Jeng, Emily K, Rhode, Peter R, Wong, Hing C, Fehniger, Todd A

    Published 2014
    Get full text Get full text
    Text
    Save to List
    Saved in:
  8. 8
    Effectiveness of two different dose administration regimens of an IL-15 superagonist complex (ALT-803) in an orthotopic bladder cancer mouse model

    Effectiveness of two different dose administration regimens of an IL-15 superagonist complex (ALT-803) in an orthotopic bladder cancer mouse model by Furuya, Hideki, Chan, Owen T. M., Pagano, Ian, Zhu, Chengjun, Kim, Nari, Peres, Rafael, Hokutan, Kanani, Alter, Sarah, Rhode, Peter, Rosser, Charles J.

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  9. 9
    Novel Human Interleukin-15 Agonists

    Novel Human Interleukin-15 Agonists by Zhu, Xiaoyun, Marcus, Warren D., Xu, Wenxin, Lee, Hyung-Il, Han, Kaiping, Egan, Jack O., Yovandich, Jason L., Rhode, Peter R., Wong, Hing C.

    Published 2009
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  10. 10
    Evaluation of the biological activities of the IL-15 superagonist complex, ALT-803, following intravenous versus subcutaneous administration in murine models

    Evaluation of the biological activities of the IL-15 superagonist complex, ALT-803, following intravenous versus subcutaneous administration in murine models by Liu, Bai, Jones, Monica, Kong, Lin, Noel, Terra, Jeng, Emily K., Shi, Sixiang, England, Christopher G., Alter, Sarah, Miller, Jeffrey S., Cai, Weibo, Rhode, Peter R., Wong, Hing C.

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  11. 11
    Novel antitumor mechanism-of-action of an IL-2 fusion protein mediated by tumor associated macrophage repolarization and innate-like CD8+ memory T cells

    Novel antitumor mechanism-of-action of an IL-2 fusion protein mediated by tumor associated macrophage repolarization and innate-like CD8+ memory T cells by Xu, Wenxin, Egan, Jack O, Liu, Bai, Chen, Xiaoyue, You, Lijing, Han, Kaiping, Marcus, Warren D, Kong, Lin, Jones, Monica, Jeng, Emily K, Rhode, Peter R, Wong, Hing C

    Published 2014
    Get full text Get full text
    Text
    Save to List
    Saved in:
  12. 12
    Interleukin-15:Interleukin-15 receptor α scaffold for creation of multivalent targeted immune molecules

    Interleukin-15:Interleukin-15 receptor α scaffold for creation of multivalent targeted immune molecules by Wong, Richard L., Liu, Bai, Zhu, Xiaoyun, You, Lijing, Kong, Lin, Han, Kai-Ping, Lee, Hyung-il, Chavaillaz, Pierre-Andre, Jin, Moonsoo, Wang, Yi, Rhode, Peter R., Wong, Hing C.

    Published 2011
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  13. 13
    Phase 1 trial of ALT-801, an interleukin-2/T cell receptor fusion protein targeting p53 (aa264-272)/HLA-A*0201 complex, in patients with advanced malignancies

    Phase 1 trial of ALT-801, an interleukin-2/T cell receptor fusion protein targeting p53 (aa264-272)/HLA-A*0201 complex, in patients with advanced malignancies by Fishman, Mayer N., Thompson, John A., Pennock, Gregory K., Gonzalez, Rene, Diez, Luz M., Daud, Adil I., Weber, Jeffery S., Huang, Bee Y., Tang, Shamay, Rhode, Peter R., Wong, Hing C.

    Published 2011
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  14. 14
    Intravesical ALT-803 and BCG Treatment Reduces Tumor Burden in a Carcinogen Induced Bladder Cancer Rat Model; a Role for Cytokine Production and NK Cell Expansion

    Intravesical ALT-803 and BCG Treatment Reduces Tumor Burden in a Carcinogen Induced Bladder Cancer Rat Model; a Role for Cytokine Production and NK Cell Expansion by Gomes-Giacoia, Evan, Miyake, Makito, Goodison, Steve, Sriharan, Aravindhan, Zhang, Ge, You, Lijing, Egan, Jack O., Rhode, Peter R., Parker, Alexander S., Chai, Karl X., Wong, Hing C., Rosser, Charles J.

    Published 2014
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  15. 15
    IL-15:IL-15 receptor alpha superagonist complex: High-level co-expression in recombinant mammalian cells, purification and characterization

    IL-15:IL-15 receptor alpha superagonist complex: High-level co-expression in recombinant mammalian cells, purification and characterization by Han, Kai-ping, Zhu, Xiaoyun, Liu, Bai, Jeng, Emily, Kong, Lin, Yovandich, Jason L., Vyas, Vinay V., Marcus, Warren D., Chavaillaz, Pierre-Andre, Romero, Christian A., Rhode, Peter R., Wong, Hing C.

    Published 2011
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  16. 16
    Efficacy and Mechanism-of-Action of a Novel Superagonist Interleukin-15: Interleukin-15 Receptor α/Fc Fusion Complex in Syngeneic Murine Models of Multiple Myeloma

    Efficacy and Mechanism-of-Action of a Novel Superagonist Interleukin-15: Interleukin-15 Receptor α/Fc Fusion Complex in Syngeneic Murine Models of Multiple Myeloma by Xu, Wenxin, Jones, Monica, Liu, Bai, Zhu, Xiaoyun, Johnson, C. Bryce, Edwards, Ana C., Kong, Lin, Jeng, Emily K., Han, Kaiping, Marcus, Warren D., Rubinstein, Mark P., Rhode, Peter R., Wong, Hing C.

    Published 2013
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  17. 17
    A Novel Fusion of ALT-803 (Interleukin (IL)-15 Superagonist) with an Antibody Demonstrates Antigen-specific Antitumor Responses

    A Novel Fusion of ALT-803 (Interleukin (IL)-15 Superagonist) with an Antibody Demonstrates Antigen-specific Antitumor Responses by Liu, Bai, Kong, Lin, Han, Kaiping, Hong, Hao, Marcus, Warren D., Chen, Xiaoyue, Jeng, Emily K., Alter, Sarah, Zhu, Xiaoyun, Rubinstein, Mark P., Shi, Sixiang, Rhode, Peter R., Cai, Weibo, Wong, Hing C.

    Published 2016
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  18. 18
    Inhibition of Acute Vascular Thrombosis in Chimpanzees by an Anti-Human Tissue Factor Antibody Targeting the Factor X Binding Site

    Inhibition of Acute Vascular Thrombosis in Chimpanzees by an Anti-Human Tissue Factor Antibody Targeting the Factor X Binding Site by Jiao, Jin-an, Kelly, Andrew B., Marzec, Ulla M., Nieves, Esperanza, Acevedo, Jorge, Burkhardt, Martin, Edwards, Ana, Zhu, Xiao-yun, Chavaillaz, Pierre-Andre, Wong, Alice, Wong, Jeffrey L., Egan, Jack O., Taylor, Dean, Rhode, Peter R., Wong, Hing C.

    Published 2009
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  19. 19
    Immunotherapeutic HCW9218 augments anti-tumor activity of chemotherapy via NK cell-mediated reduction of therapy-induced senescent cells

    Immunotherapeutic HCW9218 augments anti-tumor activity of chemotherapy via NK cell-mediated reduction of therapy-induced senescent cells by Chaturvedi, Pallavi, George, Varghese, Shrestha, Niraj, Wang, Meng, Dee, Michael J., Zhu, Xiaoyun, Liu, Bai, Egan, Jack, D'Eramo, Francesca, Spanoudis, Catherine, Gallo, Victor, Echeverri, Christian, You, Lijing, Kong, Lin, Fang, Byron, Jeng, Emily K., Rhode, Peter R., Wong, Hing C.

    Published 2022
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  20. 20
    PHASE I TRIAL OF ALT-803, A NOVEL RECOMBINANT INTERLEUKIN-15 COMPLEX, IN PATIENTS WITH ADVANCED SOLID TUMORS

    PHASE I TRIAL OF ALT-803, A NOVEL RECOMBINANT INTERLEUKIN-15 COMPLEX, IN PATIENTS WITH ADVANCED SOLID TUMORS by Margolin, Kim, Morishima, Chihiro, Velcheti, Vamsidhar, Miller, Jeffrey S., Lee, Sylvia M., Silk, Ann W., Holtan, Shernan G., Lacroix, Andreanne M., Fling, Steven P., Kaiser, Judith C., Egan, Jack O., Jones, Monica, Rhode, Peter R., Rock, Amy D., Cheever, Martin A., Wong, Hing C., Ernstoff, Marc S.

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:

Search Tools: